RBC Europe’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.8M Buy
48,285
+895
+2% +$36.4K 0.09% 85
2022
Q1
$2.1M Buy
47,390
+1,280
+3% +$55.5K 0.09% 83
2021
Q4
$1.96M Sell
46,110
-878
-2% -$36.9K 0.09% 85
2021
Q3
$2.04M Buy
46,988
+2,531
+6% +$112K 0.08% 106
2021
Q2
$1.9M Buy
44,457
+2,520
+6% +$106K 0.09% 112
2021
Q1
$1.62M Buy
41,937
+270
+0.6% +$10.2K 0.09% 111
2020
Q4
$1.5M Buy
41,667
+3,845
+10% +$139K 0.09% 112
2020
Q3
$1.45M Buy
37,822
+7,125
+23% +$275K 0.1% 104
2020
Q2
$1.08M Buy
30,697
+1,580
+5% +$56.9K 0.08% 119
2020
Q1
$950K Buy
29,117
+14,545
+100% +$568K 0.09% 106
2019
Q4
$659K Buy
14,572
+630
+5% +$26.4K 0.06% 138
2019
Q3
$567K Buy
13,942
+1,340
+11% +$56.8K 0.06% 150
2019
Q2
$542K Buy
12,602
+1,000
+9% +$38.5K 0.05% 152
2019
Q1
$445K Sell
11,602
-4,050
-26% -$155K 0.05% 158
2018
Q4
$553K Buy
15,652
+140
+0.9% +$5.08K 0.07% 141
2018
Q3
$597K Buy
15,512
+1,544
+11% +$53.9K 0.07% 144
2018
Q2
$457K Buy
13,968
+840
+6% +$25.3K 0.05% 166
2018
Q1
$359K Buy
13,128
+2,625
+25% +$71.3K 0.04% 185
2017
Q4
$260K Hold
10,503
0.03% 219
2017
Q3
$306K Buy
+10,503
New +$290K 0.04% 200

Other funds holding BSX

RBC Europe's BSX Position: Q2 2022 in Review

RBC Europe increased its Boston Scientific (BSX) stake by 1.9% in Q2 2022, buying an estimated $36.4K and bringing the position to 48,285 shares worth $1.8M. The position accounts for 0.09% of the portfolio, ranked #85.

RBC Europe first reported a position in BSX in Q3 2017 and has held it in 20 quarters since. The position peaked at $2.1M in Q1 2022. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • RBC Europe held 48,285 shares of Boston Scientific worth $1.8M as of Q2 2022.
  • RBC Europe bought 895 Boston Scientific shares in Q2 2022, an estimated $36.4K.
  • Boston Scientific made up 0.09% of RBC Europe's portfolio in Q2 2022, its #85 holding.
  • RBC Europe first reported a position in Boston Scientific in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Boston Scientific position peaked at $2.1M in Q1 2022.
  • 879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.